Anthera Pharmaceuticals 

We are focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs.

Find out more about what we are doing for patients with Cystic Fibrosis and IgA Nephropathy:

Cystic Fibrosis
IgA Nephropathy

Anthera Pharmaceuticals Announces First Patient Screened in RESULT Pivotal Phase 3 Clinical Study of Sollpura. Read more

Anthera Pharmaceuticals Provides Business Update and Reports 2017 First Quarter Financial Results. Read more

Print Friendly